Company Search:
Advanced Search
Sponsored Links
Aurobindo Pharma Ltd Company Snapshot
Aurobindo Pharma Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aurobindo Pharma Ltd with three other companies in this sector in India: Cipla Ltd (2018 sales of 151.56 billion Indian Rupees [US$2.17 billion] of which 100% was Pharmaceuticals), Dr.Reddy's Laboratories Ltd (142.03 billion Indian Rupees [US$2.04 billion] of which 80% was Global Generics), and Lupin Ltd (158.04 billion Indian Rupees [US$2.27 billion] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended March of 2018, sales at Aurobindo Pharma Ltd were 164.63 billion Indian Rupees (US$2.36 billion). This is an increase of 10.4% versus 2017, when the company's sales were 149.10 billion Indian Rupees. This was the fifth consecutive year of sales increases at Aurobindo Pharma Ltd (and since 2013, sales have increased a total of 185%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aurobindo Pharma Ltd
  Stock Performance Chart for Aurobindo Pharma Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 789.55
(Figures in Indian Rupees)
1 Week 1.6%   13 Weeks 2.8%  
4 Weeks 2.5%   52 Weeks 27.6%  
Aurobindo Pharma Ltd Key Data:
  Ticker: AUROPHARMA Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 164,630,300,000
(Year Ending Jan 2019).
Employees: 17,332
  Currency: Indian Rupees Market Cap: 462,597,345,000
  Fiscal Yr Ends: March Shares Outstanding: 585,900,000
  Share Type: Ordinary Closely Held Shares: 306,343,801
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.